NEW YORK CITY, NY / ACCESS Newswire / February 11, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ:BIOA) and certain of its senior executives for potential violations of the federal securities laws. If you invested in BioAge, you are encouraged […]
NEW YORK, NY / ACCESSWIRE / February 11, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Nextracker Inc. (NASDAQ:NXT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Nextracker, you are encouraged to obtain
NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are
The Law Offices of Frank R. Cruz announces that investors with losses related to Joint Stock Company Kaspi.kz (“Kaspi” or the “Company”) (NASDAQ: KSPI) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN JOINT STOCK COMPANY KASPI.KZ (KSPI), CLICKHEREBEFORE FEBRUARY 18, 2025 (THE LEAD
(NASDAQ:CCNE), CLEARFIELD, Pa., Feb. 11, 2025 (GLOBE NEWSWIRE) — The Board of Directors of CNB Financial Corporation (Nasdaq: CCNE) declared a quarterly cash dividend of $0.18 per share of common stock payable on March 14, 2025 to common stock shareholders of record as of February 28, 2025. CNB Financial Corporation is a financial holding company
Nordstrom, Inc. (NYSE: JWN) announced that it will report its fourth quarter 2024 financial results after the close of the financial markets on Tuesday, March 4, 2025. Given the pending acquisition by members of the Nordstrom family and El Puerto de Liverpool, S.A.B. de C.V., the company is not hosting a conference call for the
PRA Group, Inc. (Nasdaq: PRAA), a global leader in acquiring and collecting nonperforming loans, will report its fourth quarter and full year 2024 results after market close on Wednesday, February 19, 2025, followed by a webcast and conference call at 5 p.m. E.T. https://mma.prnewswire.com/media/819349/PRA_Logo.jpg To listen to PRA Group's webcast and view the corresponding slides,
W. P. Carey Inc. (NYSE: WPC) (W. P. Carey or the Company), a net lease real estate investment trust, today reported its financial results for the fourth quarter and full year ended December31, 2024. Financial Highlights 2024 FourthQuarter Full YearNet income attributable to W. P. Carey (millions) $47.0 $460.8Diluted earnings per share $0.21 $2.09AFFO (millions)
Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced that company management will participate in the following investor conferences: — Oppenheimer 35th Annual Healthcare Life Sciences Conference, February 11-12, 2025 — Format: Fireside chat and one-on-one
Mercury General Corporation (NYSE: MCY) reported today the fourth quarter and fiscal 2024 results: Consolidated Highlights Three Months Ended Change Twelve Months Ended Change December 31, December 31, 2024 2023 $ % 2024 2023 $ %(000's except per-share amounts and ratios)Net premiums earned $ 1,352,101 $ 1,144,895 $ 207,206 18.1% $ 5,075,456 $ 4,274,378 $